Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-02-13
2007-02-13
Stockton, Laura L. (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S387000
Reexamination Certificate
active
10777067
ABSTRACT:
A benzimidazole derivative or its medically acceptable salt, represented by the following formula (1), that is a human chymase activity inhibitor capable of being applied clinically:wherein, R1and R2represent a hydrogen atom, an alkyl group or an alkoxy group, etc., A represents an alkylene group or an alkenylene group, E represents —COOR3, —SO3R3, —CONHR3or —SO2NHR3, etc., G represents an alkylene group, M represents a single bond or —S(O)m—, J represents a heterocyclic group, and X represents —CH═ or a nitrogen atom.
REFERENCES:
patent: 2336909 (2000-01-01), None
patent: 1 097 926 (2001-05-01), None
patent: 2 430 950 (1980-02-01), None
patent: 62-212386 (1987-09-01), None
patent: 1-265089 (1989-10-01), None
patent: WO 99/26932 (1999-06-01), None
patent: WO 00/03997 (2000-01-01), None
patent: WO 01/00615 (2001-01-01), None
Golub et al., Science, vol. 286, Oct. 15, 1999, pp. 531-537.
Matsumoto Yoshiyuki
Mizuno Tsuyoshi
Saitou Hiroshi
Tsuchiya Naoki
Stockton Laura L.
Teijin Limited
LandOfFree
Benzimidazole derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzimidazole derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazole derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3860405